
Why Use the Virchow Medical Crow’s Nest Biopsy Catchment System? To Improve Core Needle Biopsy Collection, Tissue Management, and Access to Targeted Diagnostics.
Virchow Medical, Inc. has raised $4.1M in total funding. The most recent round was Seed.
Virchow Medical, Inc. is headquartered in San Diego, CA.
Why Use the Virchow Medical Crow’s Nest Biopsy Catchment System? To Improve Core Needle Biopsy Collection, Tissue Management, and Access to Targeted Diagnostics.
Tumor cell material from a single biopsy is often wasted, limiting the number of diagnostic answers it can yield.
Virchow offers the Crow's Nest Biopsy Catchment System and a companion Virchow Vault registry to capture and preserve more tissue from a single biopsy for broader downstream testing.
The company frames its work as building on the historical legacy of biopsy pioneer Dr. Rudolf Virchow and markets a proprietary catchment device plus a vault/registry system aimed at pathologists, oncologists, and clinical genomic testing labs.
Co-founded in 2023 (originally as Corramedical, Inc., renamed Virchow Medical in 2025) by Dr. Wilfrido Mojica and a co-founder surnamed Arrow; the San Diego company raised a $4M seed round led by Cerberus Ventures.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.